Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2006 | 03-2006 | 03-2005 | 03-2004 | 03-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 5,670 | 0 | 0 | 44,550 |
| Depreciation Amortization | N/A | 25,280 | 0 | 0 | 8,400 |
| Other Working Capital | N/A | -15,010 | 0 | 0 | -27,510 |
| Other Operating Activity | 0 | 1,180 | 0 | 0 | 4,200 |
| Operating Cash Flow | $N/A | $17,120 | $0 | $0 | $29,640 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -47,940 | 0 | 0 | -42,870 |
| Net Acquisitions | N/A | 0 | 0 | 0 | -6,430 |
| Other Investing Activity | 0 | 11,910 | 0 | 0 | -570 |
| Investing Cash Flow | $N/A | $-36,030 | $0 | $0 | $-49,870 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 6,470 | 0 | 0 | 190 |
| Financing Cash Flow | $N/A | $6,470 | $0 | $0 | $190 |
| Exchange Rate Effect | N/A | -60 | 0 | 0 | 20 |
| Beginning Cash Position | N/A | 85,330 | 0 | 0 | 150,730 |
| End Cash Position | N/A | 72,820 | 0 | 0 | 130,710 |
| Net Cash Flow | $N/A | $-12,500 | $0 | $0 | $-20,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 17,120 | 0 | 0 | 29,640 |
| Free Cash Flow | 0 | 17,120 | 0 | 0 | 29,640 |